Fibroblast growth factors (FGF) and their receptors play an important role in cell proliferation, angiogenesis and embryonal development. In this study, we show that expression of the FGF receptor-2 (FGFR-2) protein is induced in the mid-to-late G1 phase of the cell cycle in serum-starved mouse NIH3T3 cells released from starvation. Transcription of mouse FGFR-2 was activated by E2F-1. Analysis of various mouse FGFR-2 promoter mutant constructs showed that a sequence located þ 57/ þ 64 downstream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation. The promoter activity of the mouse FGFR-2 gene is also positively regulated by E2F-2 and E2F-3, but not by E2F-4 and E2F-5. Moreover, the E2F-1-induced activation of mouse FGFR-2 gene transcription is suppressed by pRB. Taken together, the results demonstrate that FGFR-2 is a new class of targets for E2F, and expression of mouse FGFR-2 in mid-to-late G1 phase would be mediated, at least in part, by the activation of a pRB/E2F pathway.
Fibroblast growth factors (FGFs) and their receptors regulate several biological activities including cell growth and differentiation, angiogenesis, malignant transformation and embryonal development. To date, 20 distinct FGFs and four FGF receptors (FGFRs) have been discovered (Powers et al., 2000) . The FGFR family is comprised of transmembrane proteins containing three extracellular immunoglobulin (Ig)-like domains (designated IgI, IgII and IgIII), an acidic region between IgI and IgII, and an intracellular tyrosine kinase domain (Powers et al., 2000) . The family has a highly conserved amino-acid sequence (Johnson and Williams, 1993) . The protein structure of the FGFRs places them in the Ig superfamily of receptors, together with the platelet-derived growth factor (PDGF)-a receptor (PDGFaR), PDGFbR and interleukin-1 receptor (IL-1R) (Johnson et al., 1990) . The 20 known types of FGFs have diverse effects on a variety of target cells (fibroblasts, endothelial cells, keratinocytes, etc.) . In order to achieve this kind of diversity, the FGF signaling system requires variation at the level of the receptors. A multitude of variants of these FGFRs is generated by alternative splicing.
In general, the FGFR-1 and FGFR-2 genes exhibit broad but distinct patterns of expression during development and in adult animals. On the other hand, the FGFR-3 and FGFR-4 genes appear to have more restricted patterns of expression. FGFR-3 transcripts are expressed predominantly in the brain, spinal chord and cartilage rudiments of developing bone (Peters et al., 1993) , and FGFR-4 transcripts are expressed in developing endoderm skeletal muscle (Stark et al., 1991) . Although the promoter regions of all murine FGFRs have been identified, the mechanisms of the transcriptional regulation are still not well understood.
The E2F family of transcription factors are key participants in a number of cellular events. Most, if not all, are growth/cell cycle-regulated proteins involved in the control of the cell cycle (e.g. cdk2 and 4, cyclins A, D and E), DNA synthesis (e.g. PCNA, DNA polymerase a, ribonucleotide reductase), or nuclear transcription (cmyc, N-myc and B-myb) (Yamazaki, 1998) . In mammals, the E2F family has six members (E2F-1 to -6), which can be placed into three groups, E2F-1 to -3, E2F-4 and -5, and E2F-6, based on homology (Black and Azizkhan-Clifford, 1999) . All the members can heterodimerize with the DP family (DP1 and DP2) (Helin et al., 1993; Zhang and Chellappan, 1995) . The importance of this large family to the regulation of E2F-dependent transcription is highlighted by the fact that individual members are conserved in mammals (Yamazaki, 1998) . The transcriptional activity of E2F-1 is negatively regulated by the product of the retinoblastoma tumor suppresor gene (pRB) or the related family members p107 and p130 and is indirectly regulated by a specific cyclin, such as the D-type cyclins and their associated kinases (Cdk4 and Cdk6).
Recently, we found that the expression of FGFR-1 was elevated at both the mRNA and protein levels in cells overexpressing cyclin D1, and this increase in expression was mediated through the activation of cyclin D1 via the pRB-E2F pathway (Tashiro et al., 2003) . We also found the expression of FGFR-2 protein to be increased in fibroblasts overexpressing cyclin D1, indicating that it is also regulated by a cyclin D1/pRB/ E2F pathway. In the present study, we show that the expression of FGFR-2 protein is induced in mid-to-late G1 in serum-starved NIH3T3 cells released from starvation, similar to other E2F-1-responsive genes. We also show that FGFR-2 expression is directly activated by E2F-1 and suppressed by pRB.
To examine the expression levels of FGFR-2 during G1 phase, extracts of serum-starved and restimulated NIH3T3 cells were collected at various time points, up to 20 h following serum stimulation, and examined by Western blot analysis. As shown in Figure 1a , there was an increase in the expression of 145 kDa FGFR-2 at 16 h after the release from serum starvation. This result indicates that the expression of FGFR-2 occurred in mid-to-late G1, because serum-starved NIH3T3 cells began to enter the S phase at about 20 h after serum stimulation, which was monitored by DNA synthesis as measured by [ 3 H]thymidine incorporation (data not shown). The time point of the expression of 145 kDa FGFR-2 is similar to that of cyclin E, which is known to be regulated by E2F-1 (Ohtani et al., 1995; Botz et al., 1996; Geng et al., 1996) . The expression of cyclin D1 and the hyperphosphorylated form of pRB occurred earlier than the induction of FGFR-2, as well as cyclin E. Furthermore, the Northern blot analysis showed that it began to strongly increase the FGFR-2 mRNA at 12 h after the release from serum starvation (Figure 1b) , suggesting that FGFR-2 expression was increased at the level of transcription. Taken together with our previous finding that expression of FGFR-2 protein was increased in cells overexpressing cyclin D1 (Figure 1c, d) , these results indicate that the expression of FGFR-2 is regulated by cyclin D1, presumably through the phosphorylation of pRB, which would result in the inactivation of pRB and activation of E2F-1.
To substantiate these claims, we next sought evidence that the FGFR-2 gene is transcriptionally regulated by E2F-1. The nucleotide sequence of the 5 0 -flanking region of the mouse FGFR-2 (mFGFR-2) gene has already been reported (Avivi et al., 1992) . Therefore, we generated a mouse FGFR-2 promoter-luciferase construct containing a mFGFR-2 promoter with the 5 0 end residing at position À642 and the 3 0 end at position þ 472 relative to the transcriptional initiation site and inserted it into a luciferase reporter construct (designated À642/ þ 472). This promoter construct was used to study transient gene expression by transfecting mouse fibroblast NIH3T3 cells and evaluating the Firefly luciferase activity by measuring the production of chemiluminescence with a luminometer. Transfection efficiency was normalized by a dual luciferase assay, which was used to measure the corresponding Renilla luciferase activity on cotransfection of the pRL-CMV plasmid. As shown in Figure 2 , the À642/ þ 472 mFGFR-2 promoter construct was stimulated approximately fourfold by coexpression with wild-type E2F-1. However, neither a mutant defective in DNA-binding (E2F-1(132E)) nor one defective in transcription activity (E2F-1(1-368)) (Qin et al., 1995) stimulated activity from the À642/ þ 472 mFGFR-2 promoter construct. These results indicated that expression of mFGFR-2 was regulated by E2F-1. E2F activity is accompanied by a binding to E2F-responsive sequences in the target genes. The E2F-responsive sequence was originally identified as 'TTTCGCGC' in the adenovirus E2 promoter (Kovesdi et al., 1986) and similar sequences were soon recognized in the promoters of various other genes. Thus, we searched for E2F-responsive sequences in the mouse FGFR-2 promoter region using TFSEARCH (ver. 1.3), and found four matches at positions À263/À256 (5
. Next, to identify the critical E2F responsive-sequences, which activate the mFGFR-2 promoter construct, we generated various deletion mutants as indicated in Figure 3a , and examined whether they are activated by E2F-1. As shown in Figure 3b , all the deletion mutants remained fully responsive to E2F-1, the same as the À642/ þ 472 mFGFR-2 promoter construct. These results suggested that the critical E2F-responsive site would be at position þ 57/ þ 64. To determine that the E2F-1-responsive site in the mFGFR-2 promoter is at position þ 57/ þ 64, we introduced a point mutation at position þ 59 (G to T) in Figure 1 Serum-induced FGFR-2 protein expression. (a) Western blot analysis. Serum-starved NIH3T3 cells were stimulated with 5% serum. At the indicated times (h) after the addition of serum, the cells were collected, lysed in extraction buffer (HEPES 50 mm: pH 7.5, NaCl 150 mm, EGTA 2.5 mm, EDTA 1 mm, DTT 1 mm, Tween-20 0.1%, sodium b-glycerophosphate 10 mm, NaF 1 mm, Na 3 VO 4 0.1 mm, grycerol 10%, and PMSF 0.1 mm), and analysed by Western blotting using a rabbit polyclonal anti-FGFR2 antibody, anticyclin D1 antibody, anti-E2F-1 antibody (Santa Cruz Biotechnology), anticyclin E antibody (UBI), anti-pRB antibody (Pharmingen), or a mouse monoclonal antitubulin antibody (Sigma). Immunodetection was performed using the Enhanced Chemiluminescence Reagent (NEN Life Science Products). (b) Northern blot analysis. Serum-starved NIH3T3 cells were stimulated with 5% serum. At the indicated times (h) after the addition of serum, the cells were collected and cellular RNA was isolated using TRIZol (GIBCO BRL). In all, 20 mg of total RNA were electrophoresed in a 1% agarose gel, transferred to a nitrocellulose membrane, and probed with [ 
by site-directed mutagenesis (designated G59T) into À642/ þ 472 mFGFR-2 promoter construct. The G59T construct showed a reduced response to E2F-1 compared to the À642/ þ 472 mFGFR-2 promoter construct (Figure 3b ). To confirm these observations, an electrophoretic mobility shift assay (EMSA) was performed using probes derived from E2F-1 responsive-like sequences at À263/À256 or þ 57/ þ 64. We prepared E2F-1/DP1 complex from nuclear extracts of 293T cells, which were transiently cotransfected with HA-tagged E2F-1 plasmid and HA-tagged DP1 plasmid, because DP1 is an obligate binding partner of E2F-1 and is required for E2F-1 binding to target sites. As shown in Figure 3c , the oligonucleotide probe with the sequence þ 57/ þ 64 formed a complex with E2F-1/DP-1, and the cold oligonucleotide with sequence þ 57/ þ 64 competed with specifically 32 P-labeled oligonucleotide probe with the sequence þ 57/ þ 64, and the complex between 32 Plabeled oligonucleotide probe with the sequence þ 57/ þ 64 and E2F-1/DP-1 was supershifted by anti E2F-1 antibody. On the other hand, the E2F-1/DP-1 complex failed to bind to the oligonucleotide with À263/À256 (data not shown). Furthermore, although the wild-type oligonucleotide with the sequence þ 57/ þ 64 (5 0 -GCGCGGAA-3 0 ) could compete with specifically 32 Plabeled oligonucleotide probe with the sequence þ 57/ þ 64, the G59T oligonucleotide (5 0 -GCTCGGAA-3 0 ) could not compete (Figure 3d ). The binding ability of G59T point mutant to E2F-1/DP1 complex was 100-fold less than that of wild-type. Thus, the oligonucleotide derived from mutated þ 57/ þ 64 (5 0 -GCTCGGAA-3 0 ) was confirmed to have lost the ability to bind the E2F-1/DP-1 complex. These results indicated that the responsiveness of the mFGFR-2 promoter to E2F-1 is dependent on the E2F-responsive sequence located at þ 57/ þ 64. Furthermore, to substantiate the possibility that E2F-1 can bind to endogenous mFGFR-2 promoter, ChIP assays were performed using an antibody against E2F-1. The immunoprecipitated chromatin by E2F-1 antibody was Figure 2 E2F-1 activates the mFGFR-2 promoter construct in NIH3T3 cells. We generated a 1114 bp fragment of the mouse FGFR-2 promoter sequence that contains a 642 bp sequence upstream of the transcriptional initiation site (Avivi et al., 1992) . The mouse genomic DNA (100 ng) was used for amplification under the following PCR conditions: 40 cycles of denaturation for 10 s at 981C, and annealing and extension for 2 min at 721C. Specific primers corresponding to the 5 0 end of the mouse FGFR-2 promoter (5 0 -CTGTTCTCGAGTGCCTTTTCCCATG-3 0 ) at nucleotide position À642 upstream of the transcriptional initiation site and the 3 0 end (5 0 -ATGCTCGAGCTCCTCTGCGC-3 0 ) at position þ 472 downstream of the transcriptional initiation site were based on a previous report (Avivi et al., 1992) . The amplified mFGFR-2 promoter fragment was subcloned into the pBluescript vector and sequenced. The mFGFR-2 promoter fragment was then excised by digestion with XhoI and subcloned into pGL3-Basic (Promega) to create the mFGFR-2 promoter/luciferase plasmid. NIH3T3 cells were cotransfected with 1 mg of mouse FGFR-2 promoter construct (À642/ þ 472), 30 ng of control plasmid pRL-CMV, and HA-tagged E2F-1 or HA-tagged mutant E2F-1 plasmids (triangle represents 10 and 100 ng) and increasing amounts of the expression plasmids using LipofectAmine Reagent (Gibco Life Technologies). Cells were harvested 24 h after transfection and assayed by the dual luciferase assay (Promega). Luciferase activity was normalized to the corresponding Renilla luciferase activity in the same transfection experiments Figure 3 Characterization of the E2F-1-responsive sequence in the mFGFR-2 promoter region. (a) Schematic illustration of the mouse FGFR-2 promoter and its truncation or G59T site-directed point mutants. The slashed circles represent the positions of E2F-responsive-like sequences. (b) Response of truncation mutant constructs or G59T site-directed point mutant construct to E2F-1. NIH3T3 cells were cotransfected with 1 mg of the mFGFR-2 promoter construct (À642/ þ 472), progressively deleted mFGFR-2 promoter constructs, or G59T site-directed mutated mFGFR-2 promoter construct together with 100 ng of the HA-tagged E2F-1 plasmid and 30 ng of control plasmid pRL-CMV and increasing amounts of the expression plasmids. Cells were harvested 24 h after transfection and assayed by the dual luciferase assay. (c) EMSA assays. Nuclear extracts from 293T cells cotransfected with HA-tagged E2F-1 plasmid and HA-tagged DP1 plasmid were prepared using HEPES buffer containing 420 mm NaCl. Extracts were incubated with a 32 P-labeled DNA probe corresponding to À263 to À256 or þ 57 to þ 64 of the mouse FGFR-2 promoter region in binding buffer (HEPES 4 mm: pH 7.9, glycerol 4%, KCl 20 mm, EDTA 0.04 mm, DTT 0.1 mm, BSA 0.8 mg/ml, and sonicated salmon sperm DNA 0.4 mg). Protein-DNA complexes were separated on a 4% polyacrylamide gel and visualized by autoradiography. Complexes were supershifted by preincubation with a monoclonal antibody against E2F-1 (KH-95, Santa Cruz) for 30 min on ice before addition of a 32 P-labeled probe. (*) represents E2F-1/DP1 complex and (**) supershifted E2F-1/DP1 complex detected with anti-E2F-1 antibody (KH-95). (d) Binding inability of the G59T site-directed point mutant to E2F-1/DP1 complex. Nuclear extracts from 293T cells cotransfected with HA-tagged E2F-1 plasmid and HA-tagged DP1 plasmid were incubated with a 32 P-labeled DNA probe corresponding to þ 57 to þ 64 of the mouse FGFR-2 promoter region in the presence or absence of each competitor. The sequences of each double-strand cold-competitors are indicated as followings: Wild-type oligo; 5 0 -CGGCAGGCGCGGAACGGGCG-3 0 ; G59T oligo, 5 0 -CGGCAGGCTCGGAACGGGCG-3 0 ; Nonspecific oligo, 5 0 -GGGAACAAGCTGGATGCTTT-3 0 . (e) ChIP assay. ChIP assay was performed using a modification of a previously published protocol (Takahashi et al., 2000) . NIH3T3 cell lysates were immunoprecipitated with a monoclonal antibody against E2F-1 (KH95) or control IgG. DNA isolated from immunoprecipitation was amplified by PCR with the following primers specific to the mFGFR-2 promoter. 5 0 -TGTCTCTTTGCGGCTGCTAGGCTT-3 0 and 5
Regulation of FGFR-2 expression by E2F-1 E Tashiro et al then amplified by PCR with primers specific to the mFGFR-2 promoter. A DNA fragment containing þ 57/ þ 64 region in mFGFR-2 promoter was detected, whereas when control IgG was used instead of anti-E2F-1 antibody, no detectable genomic DNA fragment was observed, as shown in Figure 3e . These results indicate that the mFGFR-2 promoter is activated by direct binding of the E2F-1/DP-1 complex to an E2F responsive-sequence located at þ 57/ þ 64. Previous studies reported that cyclin A is specifically induced by the expression of E2F-1 and -2, but not E2F-3, -4, or -5, whereas DHFR and cdk2 are preferentially activated by E2F-3 (DeGregori et al., 1997) . These observations led us to examine whether the mFGFR-2 promoter construct is activated by other E2F family members. As shown in Figure 4a , both HA-tagged E2F-2 and E2F-3 increased the activity of the À642/ þ 472 mFGFR-2 promoter construct. In contrast, neither HAtagged E2F-4 nor HA-tagged E2F-5 stimulated the activity of the À642/ þ 472 mFGFR-2 promoter construct. As the expression levels of E2F-4 and E2F-5 were not lower than that of E2F-1, E2F-2, and E2F-3 (data not shown), the inability of E2F-4 and -5 to activate the À642/ þ 472 mFGFR-2 promoter construct was not due to expression efficiency. And EMSA showed that neither E2F-4 nor E2F-5 could bind the E2F-responsive sequence located at þ 57/ þ 64 of mFGFR-2 promoter region (data not shown). Although exactly why neither E2F-4 nor E2F-5 could activate the mFGFR-2 promoter construct is unclear, it has been reported that different E2Fs have different effects on the cell cycle/ growth of cells. E2F-1, -2 and -3, but not E2F-4 or -5, have been shown to promote entry into the S phase in serum-starved or p16-arrested Rat1 fibroblasts, and serum-starved REF52 cells (Lukas et al., 1996; DeGregori et al., 1997) . Therefore, the mouse FGFR-2 promoter activated by E2F-1, -2 and -3 might affect on cell cycle/growth. pRB negatively regulates gene expression by binding to and inhibiting E2F-1. Therefore, to investigate whether the E2F-1-induced activity of the mFGFR-2 promoter is suppressed by pRB, a plasmid encoding pRB (pRC/CMV-pRB) was cotransfected with the À642/ þ 472 mFGFR-2 promoter construct and pRC/ CMV-HAE2F-1 plasmid, and luciferase activity was examined. As shown in Figure 4b , the enhanced reporter activity induced by E2F-1 was markedly inhibited by cotransfection with pRB, and the suppressive effect occurred in a dose-dependent manner. On the other hand, when the À642/ þ 472 mFGFR-2 promoter construct was cotransfected with a plasmid encoding p130 (pRC/CMV-p130), a member of the retinoblastoma family of pocket proteins, the E2F-1-induced activation of the mFGFR-2 promoter was not suppressed by p130. These results coincident with the current thinking that pRB interacts with E2F-1, E2F-2, E2F-3 and E2F-4, whereas p130 and p107 interact with E2F-4 but not with E2F-1B3 (Grana et al., 1998) . Thus, these observations strongly support that pRB suppressed E2F-1-induced activation of the mFGFR-2 promoter.
We showed here that expression of mouse FGFR-2 is induced by release from serum starvation in the mid-tolate G1 phase of the cell cycle. Transcription of mouse FGFR-2 is positively regulated by E2F-1B3 through an E2F-responsive sequence within the promoter region located at þ 57/ þ 64, and negatively regulated by pRB. The sequence of human FGFR-2 promoter region has been cloned (Ricol et al., 1999) and the E2F-responsive sequence within the mouse FGFR-2 promoter region located at þ 57/ þ 64 is not conserved within the human FGFR-2 promoter region. However, the human FGFR-2 promoter-luciferase construct was also activated by E2F-1 in transient transfection experiments, and E2F-1 overexpressing human esophageal EC109 cell lines show the elevated expression of FGFR-2 (unpublished data). Therefore, the human FGFR-2 promoter might also be regulated, at least in part, by E2F-1. Studies have shown that prolonged and continuous exposure to growth factors is required for cells to progress through the cell cycle. Recently, the prolonged requirement for the growth factor was shown to be met instead using two short pulses of mitogen (Jones and Kazlauskas, 2001) . Therefore, it is likely that the role of FGFR-2 expression in mid-to-late G1 is to function as a receptor for the second wave of growth factors and allow the cell to enter the S phase. Figure 4 (a) Effect of the E2F family of transcription factors on the mouse FGFR-2 promoter. NIH3T3 cells were cotransfected with 1 mg of the mFGFR-2 promoter construct (-642/ þ 472), 100 ng of the indicated HA-tagged E2F plasmids and 30 ng of the control plasmid pRL-CMV and increasing amounts of expression plasmids using LipofectAmine Reagent. Cells were harvested 24 h after transfection and assayed by the dual luciferase assay. (b) Effect of the pRB and p130 tumor suppressor protein on E2F-1-induced activation of the mFGFR-2 promoter. NIH3T3 cells were cotransfected with 1 mg of the mFGFR-2 promoter construct (À642/ þ 472), 50 ng of the HA-tagged E2F-1 plasmid, 10 or 50 ng of the pRB or p130 plasmids and 30 ng of the control plasmid pRL-CMV and increasing amounts of the expression plasmids using LipofectAmine Reagent. Cells were harvested 24 h after transfection and assayed by the dual luciferase assay Regulation of FGFR-2 expression by E2F-1 E Tashiro et al
